| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |